IL13 and asthma: As a result of increased expression of DPP-4, which is induced by the type 2 cytokines interleukin (IL)-4 and IL-13, in diseases of asthma and type 2 inflammation, such as atopic dermatitis and chronic rhinitis, DPP-4i may help with the management of asthma (103, 150–154).